What does CUSIP 00767E102 represent in this 13F holders report?

CUSIP 00767E102 is the security identifier for AEGR - AEGERION PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held AEGR - AEGERION PHARMACEUTICALS INC - COM in Q2 2016?

63 institutional investors reported AEGR - AEGERION PHARMACEUTICALS INC - COM for Q2 2016. Use the holders table for investor-level position and value details.

AEGERION PHARMACEUTICALS INC - COM (AEGR)

CUSIP: 00767E102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / COM
Total 13F shares: 25,844,303
Share change: -4,540,875
Total reported value: $38,501,396
Put/Call ratio: 36%
Price per share: $1.49
Number of holders: 63
Value change: -$16,676,429
Number of buys: 32
Number of sells: 69

Quarterly Holders Quick Answers

What is CUSIP 00767E102?
CUSIP 00767E102 identifies AEGR - AEGERION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of AEGERION PHARMACEUTICALS INC - COM (AEGR) as of Q2 2016

As of 30 Jun 2016, AEGERION PHARMACEUTICALS INC - COM (AEGR) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,844,303 shares. The largest 10 holders included SCOPIA CAPITAL MANAGEMENT LP, Broadfin Capital, LLC, FMR LLC, Sarissa Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Artal Group S.A., ARMISTICE CAPITAL, LLC, Jefferies Group LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 63 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.